JZ
Jawed Zia
About Jawed Zia
Data last updated:
Jawed Zia is a Director at Indisuan Pharmaceuticals Private Limited (since 2025) and Director at Acture Health Private Limited (since 2022). The companies operate in Pharma, Healthcare and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹32.53 Cr; the largest is Indisuan Pharmaceuticals Private Limited at ₹31.12 Cr (FY 2025). Earlier, Jawed Zia was a Director at Alcon Laboratories (India) Private Limited (2005–2017) and Director at Novartis Healthcare Private Limited (2014–2018) and 5 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 31 Jan 2025 | 2018 | ₹31.12 Cr (FY 2025) | Active | |
| Director | 16 Mar 2022 | 2021 | ₹1.41 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Apr 2005 | 1999 | ₹2,237 Cr (FY 2025) | Active | |
| Director | 28 Aug 2014 | 1997 | ₹6,088 Cr (FY 2025) | Active | |
| Director | 22 Sep 2017 | 1965 | ₹15.58 Cr (FY 2025) | Active | |
| Director | 01 Dec 2020 | 2013 | ₹9.23 Cr (FY 2026) | Active | |
| Whole-Time Director | 24 Mar 2021 | 2019 | ₹18.84 Cr (FY 2026) | Active | |
| Director | 01 Jun 2018 | 1944 | ₹6,685 Cr (FY 2025) | Active | |
| Managing Director | 01 Mar 2018 | 1947 | ₹398 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Jawed Zia
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amol Pramod Salvi | 11044007 | Indisuan Pharmaceuticals Private Limited | Additional Director |
| Iliya Senthil Kumar | 09446993 | Acture Health Private Limited | Director |
| Senthil Kumar Rathasarathy | 06463295 | Acture Health Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jawed Zia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jawed Zia
Jawed Zia currently holds 2 directorships: Indisuan Pharmaceuticals Private Limited (Director, since 31 Jan 2025, revenue ₹31.12 Cr (FY 2025)); Acture Health Private Limited (Director, since 16 Mar 2022, revenue ₹1.41 Cr (FY 2025)).
Jawed Zia was first appointed on 01 Apr 2005 as Director at Alcon Laboratories (India) Private Limited. The most recent appointment on record is 31 Jan 2025 at Indisuan Pharmaceuticals Private Limited.
The 2 current companies of Jawed Zia that report revenue have a combined latest revenue of ₹32.53 Cr: Indisuan Pharmaceuticals Private Limited ₹31.12 Cr (FY 2025); Acture Health Private Limited ₹1.41 Cr (FY 2025).
Jawed Zia held 7 earlier board appointments: Alcon Laboratories (India) Private Limited (Director, 01 Apr 2005 to 11 May 2017); Novartis Healthcare Private Limited (Director, 28 Aug 2014 to 15 Jan 2018); Organisation Of Pharmaceutical Producers Of India (Director, 22 Sep 2017 to 13 Apr 2018); Genei Laboratories Private Limited (Director, 01 Dec 2020 to 12 Feb 2022); Rivaara Labs Private Limited (Whole-Time Director, 24 Mar 2021 to 12 Feb 2022); and 2 more.
The current boards of Jawed Zia's companies include Amol Pramod Salvi (Indisuan Pharmaceuticals Private Limited), Iliya Senthil Kumar (Acture Health Private Limited), Senthil Kumar Rathasarathy (Acture Health Private Limited).